Prescription Required
Formulation: Tablet
(Brand Option)
Select the prescribed dosage
Select the quantity to see the price.
Prescription Required
Formulation: Tablet
(Generic Alternative)
Select the prescribed dosage
Select the quantity to see the price.
* This price includes a dispensing fee, medical review fee, and packing fee.
Shipped and delivered directly to your doorstep
Micardis HCT is a prescription oral medication used to treat high blood pressure (hypertension) in adults.
It contains two active ingredients: telmisartan and hydrochlorothiazide, which work together to lower blood pressure through different mechanisms.
Micardis HCT belongs to a class of medications called combination antihypertensives. These medications combine two blood pressure-lowering ingredients to help patients achieve better blood pressure control.
Telmisartan belongs to a group of medications called angiotensin II receptor blockers (ARBs). It works by blocking the effects of angiotensin II, a hormone that causes blood vessels to narrow.
Hydrochlorothiazide belongs to a class of medications called thiazide diuretics, commonly known as water pills. It helps the kidneys remove excess sodium and water from the body through urine.
Micardis HCT is commonly prescribed when one blood pressure medication does not provide adequate control or when a healthcare provider determines that combination treatment is appropriate.
By relaxing blood vessels and reducing excess fluid, Micardis HCT helps lower blood pressure and reduce the risk of complications associated with uncontrolled hypertension.
Micardis HCT is indicated for the treatment of hypertension in adults.
Hypertension is a long-term condition in which the pressure of blood against the walls of the arteries remains consistently elevated.
Arteries are blood vessels that carry oxygen-rich blood from the heart to different parts of the body.
When blood pressure stays too high, the heart must work harder to pump blood through the circulatory system.
Over time, this additional strain can damage blood vessels and important organs, including the heart, brain, kidneys, and eyes.
High blood pressure often develops without noticeable symptoms.
For this reason, hypertension is sometimes called a silent condition.
Some people may experience headaches or dizziness, but these symptoms are not reliable indicators of high blood pressure.
The only way to determine whether your blood pressure is elevated is to measure it regularly.
Micardis HCT helps treat hypertension by addressing two factors that contribute to increased blood pressure.
Telmisartan relaxes and widens blood vessels, allowing blood to flow more easily.
Hydrochlorothiazide helps the kidneys remove excess salt and water, reducing fluid volume in the bloodstream.
Together, these actions help lower blood pressure and reduce strain on the cardiovascular system.
Micardis HCT helps control hypertension but does not cure the condition.
Continue taking your medication as prescribed, even if you feel well or your blood pressure readings improve.
Micardis HCT may be prescribed when treatment with a single blood pressure medication does not provide adequate results.
Some patients continue to have elevated blood pressure despite following a healthy diet, exercising regularly, and taking medication.
This may happen because several processes in the body contribute to blood pressure regulation.
For example, blood vessels may remain narrowed, or the body may retain too much sodium and water.
Using medications that target different processes can provide better blood pressure control.
Micardis HCT combines telmisartan and hydrochlorothiazide in one tablet.
Telmisartan blocks the effects of angiotensin II, helping blood vessels relax.
Hydrochlorothiazide increases the removal of sodium and water through urine.
The combined effect may lower blood pressure more effectively than either ingredient alone in patients who require both medications.
Your healthcare provider will determine whether Micardis HCT is appropriate based on your blood pressure readings, previous treatments, kidney function, and overall health.
Do not add, stop, or change blood pressure medications without consulting your healthcare provider.
Controlling high blood pressure is important for reducing the risk of serious cardiovascular complications.
When blood pressure remains elevated for long periods, it can damage the inner lining of blood vessels.
This damage may contribute to narrowing and hardening of the arteries, a process called atherosclerosis.
Narrowed arteries can reduce blood flow to important organs.
High blood pressure is also a major risk factor for stroke.
A stroke occurs when blood flow to part of the brain becomes blocked or when a blood vessel in the brain ruptures.
Without enough oxygen-rich blood, brain cells can become damaged.
High blood pressure can also increase the risk of heart attack, heart failure, and kidney disease.
Micardis HCT helps lower blood pressure, which is an important part of reducing these long-term risks.
However, the medication is prescribed to treat hypertension rather than as a separate treatment for an existing stroke or heart attack.
Your healthcare provider may also recommend lifestyle changes, including reducing sodium intake, maintaining a healthy weight, and participating in regular physical activity.
Keeping your blood pressure within your recommended target range can help protect your heart, brain, kidneys, and blood vessels over time.
Micardis HCT contains two medications that work together to lower blood pressure.
Telmisartan belongs to a class of medications called angiotensin II receptor blockers, while hydrochlorothiazide is a thiazide diuretic.
These ingredients target different processes involved in blood pressure regulation.
Telmisartan helps relax blood vessels, while hydrochlorothiazide reduces excess salt and water in the body.
Together, they help blood flow more easily and reduce the pressure against artery walls.
Blocks the Effects of Angiotensin II
Angiotensin II is a hormone that helps regulate blood pressure.
It causes blood vessels to narrow, which increases resistance to blood flow.
When blood vessels become narrower, the heart must work harder to pump blood through them.
Angiotensin II also stimulates the release of aldosterone, a hormone that encourages the kidneys to retain sodium and water.
Retaining excess sodium and water can increase blood volume and contribute to higher blood pressure.
Telmisartan works by blocking angiotensin II from attaching to specific receptors called AT1 receptors.
These receptors are found in blood vessels and other tissues involved in blood pressure regulation.
By blocking these receptors, telmisartan prevents angiotensin II from producing some of its blood pressure-raising effects.
As a result, blood vessels relax and widen, allowing blood to flow with less resistance.
This helps lower blood pressure and reduces the workload on the heart.
Increases the Removal of Excess Sodium and Water
Hydrochlorothiazide works by increasing the amount of sodium and water removed from the body through urine.
The kidneys normally filter blood and regulate the body’s fluid and electrolyte balance.
Electrolytes are minerals, such as sodium and potassium, that help maintain normal nerve, muscle, and fluid function.
Hydrochlorothiazide acts on a part of the kidneys called the distal convoluted tubule.
This is an area where the kidneys normally reabsorb some sodium and chloride back into the bloodstream.
Hydrochlorothiazide blocks a transport system responsible for reabsorbing these minerals.
As a result, more sodium and chloride remain in the urine.
Water follows these minerals, increasing urine production and helping remove excess fluid from the body.
This reduces blood volume and contributes to lower blood pressure.
With continued treatment, hydrochlorothiazide also helps reduce resistance in the blood vessels, supporting its long-term blood pressure-lowering effect.
Provides Combined Blood Pressure Control
Micardis HCT combines the effects of telmisartan and hydrochlorothiazide in one tablet.
Telmisartan reduces blood vessel narrowing, while hydrochlorothiazide helps eliminate excess sodium and water.
These actions complement each other.
For example, hydrochlorothiazide may activate hormonal processes that encourage the body to raise blood pressure.
Telmisartan helps block one of the main blood pressure-raising effects of these hormones.
The combination can provide better blood pressure control than either medication alone in patients who need both treatments.
Telmisartan may also reduce some of the potassium loss associated with hydrochlorothiazide.
However, potassium levels can still become too high or too low during treatment.
Your healthcare provider may recommend blood tests to monitor your potassium, sodium, and kidney function.
Micardis HCT lowers blood pressure by relaxing blood vessels and reducing excess fluid, helping maintain more stable blood pressure throughout the day.Â
Micardis HCT begins lowering blood pressure after you start taking it, but the full benefits develop gradually.
Telmisartan can begin lowering blood pressure within approximately three hours of taking a dose.
Hydrochlorothiazide usually begins increasing urine production within about two hours.
However, increased urination does not necessarily mean that your blood pressure has reached its recommended target.
Some patients may notice lower blood pressure readings during the first several days of treatment.
The blood pressure-lowering effect of telmisartan generally becomes more noticeable over the first few weeks, with much of its maximum effect developing within approximately four weeks.
Your healthcare provider may assess your response after two to four weeks and determine whether your dosage needs adjustment.
The time required to achieve your target blood pressure depends on your starting blood pressure, other medical conditions, and response to treatment.
Micardis HCT is designed to provide blood pressure control throughout the day when taken once daily.
However, it is important to continue monitoring your blood pressure because hypertension often causes no noticeable symptoms.
Take Micardis HCT regularly, even if you feel well, and do not change your dosage without consulting your healthcare provider.
If your blood pressure remains above your recommended target range, contact your healthcare provider for advice.Â
Micardis HCT is a prescription medication used to treat high blood pressure in adults.
It is usually taken once daily, with or without food.
The appropriate dosage depends on your blood pressure readings, previous treatment, kidney function, and response to medication.
Because hydrochlorothiazide increases urine production, taking Micardis HCT in the morning may help reduce nighttime trips to the bathroom.
Possible side effects include dizziness, fatigue, increased urination, and changes in blood electrolyte levels.
Some patients may experience low blood pressure, particularly if they are dehydrated or have lost significant amounts of fluid.
Micardis HCT may also affect kidney function and potassium levels.
Tell your healthcare provider if you have kidney disease, liver problems, gout, diabetes, or a history of electrolyte imbalances.
Micardis HCT can seriously harm an unborn baby and should not be used during pregnancy.
If you become pregnant while taking Micardis HCT, stop taking the medication and contact your healthcare provider immediately to arrange an alternative blood pressure treatment.
Avoid taking potassium supplements or potassium-containing salt substitutes unless your healthcare provider recommends them.
Your healthcare provider may recommend regular blood pressure measurements and blood tests to monitor kidney function and electrolyte levels.
Continue taking Micardis HCT exactly as prescribed, even if your blood pressure improves, because stopping treatment may cause your blood pressure to rise again.
Micardis HCT is a prescription oral medication used to treat high blood pressure (hypertension) in adults.
It contains two active ingredients: telmisartan and hydrochlorothiazide.
Telmisartan helps relax and widen blood vessels, while hydrochlorothiazide helps the kidneys remove excess sodium and water from the body.
Together, these ingredients help lower blood pressure and reduce strain on the heart and blood vessels.
Micardis HCT is usually taken once daily, with or without food, depending on your healthcare provider’s instructions.
Taking Micardis HCT in the morning is often recommended because hydrochlorothiazide increases urine production. This may help prevent frequent trips to the bathroom during the night.
Your healthcare provider will determine the appropriate dosage based on your blood pressure readings, medical history, kidney function, and response to treatment.
Take Micardis HCT exactly as prescribed. Do not increase your dosage, take extra tablets, or stop treatment without consulting your healthcare provider.
Taking Micardis HCT correctly helps maintain consistent blood pressure control while reducing the risk of unwanted side effects.
The medication should be taken by mouth once daily, preferably at approximately the same time each day.
Follow these steps when taking Micardis HCT:
Micardis HCT helps control high blood pressure, but it does not cure hypertension.
Most people with high blood pressure do not experience noticeable symptoms, making regular medication use important.
Do not take additional Micardis HCT tablets to lower your blood pressure faster. Taking more than prescribed may cause dangerously low blood pressure, dehydration, or electrolyte imbalances.
Micardis HCT is usually taken once daily.
Your healthcare provider will determine the appropriate dose based on your blood pressure levels, previous treatments, and overall health.
The medication is designed to provide blood pressure control throughout the day.
Taking it at approximately the same time each day helps maintain a consistent treatment routine.
For example, if you prefer taking your medication in the morning, you may take Micardis HCT after waking up or with breakfast.
You do not need to take the medication with food unless your healthcare provider gives you specific instructions.
Avoid taking more than one prescribed daily dose unless your healthcare provider has specifically directed you to do so.
Follow your recommended dosing schedule, even if your blood pressure readings return to your target range.
The recommended dosage of Micardis HCT depends on your medical condition, blood pressure readings, and response to previous treatment.
Micardis HCT is available in different tablet strengths.
Common strengths include 40 mg/12.5 mg, 80 mg/12.5 mg, and 80 mg/25 mg.
The first number represents the amount of telmisartan, while the second represents the amount of hydrochlorothiazide.
According to U.S. prescribing information, patients whose blood pressure is not adequately controlled with telmisartan 80 mg alone may begin Micardis HCT 80 mg/12.5 mg once daily.
Patients whose blood pressure remains uncontrolled with hydrochlorothiazide 25 mg alone may also be switched to Micardis HCT 80 mg/12.5 mg once daily.
Your healthcare provider may increase the total daily dose after two to four weeks if your blood pressure remains above your target range.
The U.S. prescribing information allows titration up to a total daily dose of 160 mg of telmisartan and 25 mg of hydrochlorothiazide when necessary.
This amount is not available as a single Micardis HCT tablet and may require a specific combination of tablets prescribed by your healthcare provider.
Patients with liver problems or conditions affecting bile flow may require a lower starting dose, such as 40 mg/12.5 mg, under close medical supervision.
Micardis HCT is not recommended for patients with severe liver impairment.
Do not change your Micardis HCT dosage on your own, even if your blood pressure remains elevated.Â
Micardis HCT can be taken at any time of day, but morning administration is often preferred.
This is because hydrochlorothiazide is a diuretic, commonly called a water pill.
Diuretics help the kidneys remove excess sodium and water through urine.
As a result, you may need to urinate more frequently after taking the medication.
Taking Micardis HCT in the morning allows much of this increased urination to occur during the day.
If you take the medication shortly before bedtime, you may need to wake up during the night to use the bathroom.
This can interrupt your sleep and cause unnecessary discomfort.
If you prefer taking Micardis HCT in the afternoon or evening, try to take it at least four hours before bedtime.
However, the best dosing time depends on your personal schedule, other medications, and healthcare provider’s recommendations.
Choose a consistent time that works for you and follow the dosing schedule recommended by your healthcare provider.
Yes. Micardis HCT can be taken with or without food.
Eating a meal does not significantly interfere with the medication’s overall blood pressure-lowering effects.
You may take your tablet with breakfast, lunch, or another meal if this makes it easier to remember your dose.
You can also take it on an empty stomach if you prefer.
If you experience mild stomach discomfort after taking Micardis HCT, taking it with food may help.
Try to maintain a consistent medication routine.
For example, if you usually take Micardis HCT with breakfast, continue doing so each day.
You should also follow any dietary recommendations provided by your healthcare provider.
People with hypertension are often advised to limit excess sodium because consuming too much salt can contribute to elevated blood pressure.
Micardis HCT can be taken with or without meals, but it should always be taken according to your prescribed schedule.
Some medications used to lower cholesterol may interfere with the absorption of hydrochlorothiazide.
These include bile acid-binding medications such as cholestyramine and colestipol.
Bile acid-binding medications work in the digestive tract by attaching to substances called bile acids.
This helps the body remove more cholesterol.
However, these medications may also bind to hydrochlorothiazide and reduce the amount absorbed into the bloodstream.
If hydrochlorothiazide is not absorbed properly, Micardis HCT may become less effective at lowering blood pressure.
For this reason, your healthcare provider may recommend separating the medications.
Micardis HCT should generally be taken at least four hours before or four to six hours after cholestyramine or colestipol.
For example, if you take Micardis HCT at 8:00 AM, your healthcare provider may recommend waiting until at least noon before taking cholestyramine.
Your exact medication schedule will depend on the products and doses you use.
Tell your healthcare provider if you take cholestyramine, colestipol, or other cholesterol-lowering medications before starting Micardis HCT.Â
If you forget to take Micardis HCT, take the missed dose as soon as you remember.
However, if it is almost time for your next scheduled dose, skip the missed dose and continue with your regular medication schedule.
Do not take two doses at once to make up for a missed dose.
Taking extra Micardis HCT may cause your blood pressure to fall too low.
This can lead to dizziness, weakness, lightheadedness, or fainting.
Because the medication contains a diuretic, taking extra tablets may also increase urine production and cause dehydration.
If you frequently forget to take your medication, consider setting a daily reminder.
Contact your healthcare provider or pharmacist if you miss several doses or are unsure when to resume treatment.
Micardis HCT begins lowering blood pressure after you start taking it, but the time needed to experience its full benefits varies.
Telmisartan can begin lowering blood pressure within a few hours of taking a dose.
Hydrochlorothiazide also begins working within hours by increasing sodium and water removal through urine.
Some patients may notice lower blood pressure readings during the first few days of treatment.
However, a more consistent response usually develops with regular use.
The full blood pressure-lowering effects may take approximately four weeks to become apparent.
Your healthcare provider may evaluate your blood pressure after two to four weeks and determine whether your dosage needs adjustment.
The response depends on several factors, including your starting blood pressure, kidney function, and other medications.
Because high blood pressure often causes no symptoms, you may not physically notice the medication working.
Regular blood pressure monitoring is important for measuring your response.
Continue taking Micardis HCT as prescribed, even if you do not notice immediate changes in how you feel.
Do not stop taking Micardis HCT simply because your blood pressure readings have improved.
Micardis HCT helps control hypertension but does not permanently cure it.
Your blood pressure may be within your recommended range because the medication is working.
Stopping treatment without medical advice may cause your blood pressure to rise again.
Uncontrolled hypertension can gradually damage blood vessels and increase the risk of heart attack, stroke, kidney disease, and other cardiovascular complications.
Your healthcare provider may adjust your treatment if your blood pressure remains well controlled over time.
However, any changes should be based on your blood pressure readings, medical history, and overall cardiovascular health.
Continue taking Micardis HCT unless your healthcare provider recommends changing or stopping treatment.
If your blood pressure remains above your recommended target range while taking Micardis HCT, contact your healthcare provider.
Several factors can affect blood pressure control, including diet, physical activity, stress, medication use, and certain medical conditions.
Consuming too much sodium may also contribute to elevated blood pressure.
Your current dosage may need adjustment if your blood pressure remains consistently high.
Your healthcare provider may review your blood pressure records, kidney function, electrolyte levels, and other medications.
They may recommend adjusting your Micardis HCT dosage or adding another blood pressure medication.
Do not take extra tablets to lower your blood pressure more quickly.
Taking more than prescribed may cause dizziness, fainting, dehydration, or electrolyte disturbances.
If your blood pressure is higher than 180/120 mmHg, repeat the measurement after at least one minute and seek prompt medical advice if it remains that high.
Seek emergency medical attention if very high blood pressure occurs with chest pain, severe shortness of breath, sudden weakness, difficulty speaking, or changes in vision.
Micardis HCT may cause dizziness or lightheadedness, particularly when treatment begins or the dosage is increased.
This happens because the medication lowers blood pressure.
If your blood pressure drops too quickly, you may feel dizzy when standing up from a sitting or lying position.
This is called orthostatic hypotension.
The risk may be greater if you are dehydrated, have been sweating heavily, or have lost fluids through vomiting or diarrhea.
To reduce dizziness, stand up slowly after sitting or lying down.
If you feel lightheaded, sit or lie down until the sensation passes.
Drink enough fluids unless your healthcare provider has instructed you to limit your intake.
Avoid driving or operating machinery until you know how Micardis HCT affects you.
Contact your healthcare provider if dizziness becomes severe, occurs frequently, or causes you to faint.
Yes. Your healthcare provider may recommend blood tests to monitor kidney function and electrolyte levels during Micardis HCT treatment.
The kidneys play an important role in removing waste products and regulating the body’s fluid balance.
Micardis HCT affects both blood pressure regulation and kidney function.
Telmisartan can affect kidney filtration and potassium levels.
Hydrochlorothiazide increases the removal of sodium and water through urine.
It may also lower potassium or sodium levels in some patients.
Electrolyte imbalances can cause symptoms such as muscle cramps, weakness, unusual tiredness, dizziness, or an irregular heartbeat.
Blood tests help identify these changes before they become serious.
Your healthcare provider may monitor creatinine, potassium, sodium, and other laboratory values.
The frequency of testing depends on your age, kidney function, medical history, and treatment response.
Do not take potassium supplements or potassium-containing salt substitutes unless your healthcare provider recommends them.
Micardis HCT is intended for adults with high blood pressure and should be taken exactly as prescribed.
The medication can cause dizziness, increased urination, low blood pressure, and changes in electrolyte levels.
Avoid becoming dehydrated, especially during hot weather, strenuous exercise, or illnesses involving vomiting and diarrhea.
Tell your healthcare provider if you have kidney disease, liver problems, gout, diabetes, or a history of electrolyte imbalances.
Micardis HCT may increase uric acid levels and trigger gout attacks in susceptible patients.
It may also affect blood sugar levels, making additional monitoring necessary for some people with diabetes.
Patients with kidney problems may require closer monitoring because changes in kidney function can affect medication safety.
Micardis HCT must not be used during pregnancy because telmisartan can cause serious harm to an unborn baby.
If you become pregnant while taking Micardis HCT, stop taking it and contact your healthcare provider immediately to arrange a safer blood pressure treatment.
The medication is also not recommended during breastfeeding.
Tell your healthcare provider about all other medications and supplements you currently use, including potassium supplements, anti-inflammatory pain relievers, and cholesterol-lowering medications.
Keep Micardis HCT in its original blister packaging until immediately before taking a tablet.
Continue taking Micardis HCT as prescribed, monitor your blood pressure regularly, and attend recommended appointments to check your kidney function and electrolyte levels.
Micardis HCT (Telmisertan/Hctz) is available in the following forms and strength:
Micardis HCT is a prescription oral medication used to treat high blood pressure (hypertension) in adults.
It contains two active ingredients: telmisartan and hydrochlorothiazide, which work together to lower blood pressure.
Telmisartan belongs to a class of medications called angiotensin II receptor blockers (ARBs). It helps relax and widen blood vessels, allowing blood to flow more easily.
Hydrochlorothiazide belongs to a class of medications called thiazide diuretics. It helps the kidneys remove excess sodium and water through urine, reducing the amount of fluid in the bloodstream.
Although Micardis HCT is effective in lowering blood pressure, it may cause side effects or serious complications in certain patients.
These include low blood pressure, dehydration, electrolyte imbalances, kidney problems, and allergic reactions.
Micardis HCT can also cause serious harm to an unborn baby if taken during pregnancy.
Before starting treatment, tell your healthcare provider about any kidney or liver problems, medication allergies, pregnancy, breastfeeding, or other medical conditions.
Micardis HCT must not be used during pregnancy because it can cause serious harm to an unborn baby.
Telmisartan affects a hormone system called the renin-angiotensin system, which helps regulate blood pressure and kidney function.
This system also plays an important role in the development of a baby’s kidneys during pregnancy.
Medications that block this system can interfere with normal fetal kidney development and function.
Exposure during the second and third trimesters can cause serious complications, including reduced fetal kidney function and low amniotic fluid levels.
Amniotic fluid is the liquid that surrounds and protects a developing baby during pregnancy.
When amniotic fluid levels become too low, the baby’s lungs and other organs may not develop properly.
Severe cases may result in kidney failure, skull abnormalities, or fetal death.
Micardis HCT also contains hydrochlorothiazide, which can cross the placenta and may affect fluid and electrolyte balance.
Tell your healthcare provider if you are pregnant, planning to become pregnant, or think you may be pregnant.
Your healthcare provider can recommend another blood pressure medication with a more established safety profile during pregnancy.
If you become pregnant while taking Micardis HCT, stop taking the medication and contact your healthcare provider immediately.
Do not wait until your next scheduled appointment to report a pregnancy.
Consult your healthcare provider before using Micardis HCT if you are breastfeeding.
There is limited information about whether telmisartan passes into human breast milk.
However, hydrochlorothiazide is known to pass into breast milk.
Hydrochlorothiazide increases urine production by helping the kidneys remove excess salt and water.
High doses of diuretics may also reduce milk production in some breastfeeding mothers.
Because Micardis HCT contains two active ingredients, your healthcare provider must consider the potential effects on your baby and the importance of blood pressure treatment.
An alternative medication may be recommended during breastfeeding.
Controlling high blood pressure remains important after childbirth, especially for patients with existing hypertension or pregnancy-related blood pressure problems.
Breastfeeding is not recommended during Micardis HCT treatment. Discuss a suitable alternative with your healthcare provider.
Do not take Micardis HCT if you have a known allergy to telmisartan, hydrochlorothiazide, or any other ingredient in the medication.
Before starting treatment, tell your healthcare provider if you have experienced allergic reactions to blood pressure medications or diuretics.
Hydrochlorothiazide is a sulfonamide-derived medication.
People with a history of allergic reactions to sulfonamide-containing medications should inform their healthcare provider before taking Micardis HCT.
However, an allergy to a sulfonamide antibiotic does not automatically mean that you will be allergic to hydrochlorothiazide.
Your healthcare provider can assess your allergy history and determine whether treatment is appropriate.
Possible allergic reactions include itching, hives, skin rash, redness, or swelling.
In rare cases, a serious allergic reaction may cause swelling of the face, lips, tongue, or throat.
This type of swelling is called angioedema.
Angioedema can become dangerous when it affects the throat or airways.
Some patients may experience difficulty breathing or swallowing.
Stop taking Micardis HCT and seek emergency medical attention if you develop difficulty breathing or swelling of your face, tongue, or throat.
Do not take another dose until your healthcare provider has assessed the reaction.
Tell your healthcare provider if you have kidney disease or reduced kidney function before starting Micardis HCT.
The kidneys help filter waste products from the bloodstream and regulate the body’s fluid and electrolyte balance.
Micardis HCT affects both blood pressure regulation and kidney function.
Telmisartan blocks the effects of angiotensin II, a hormone that helps control blood vessel narrowing and kidney blood flow.
Although this action lowers blood pressure, it may also affect kidney filtration in certain patients.
The risk is greater in people with severe kidney disease, dehydration, heart failure, or narrowing of the arteries that supply blood to the kidneys.
Hydrochlorothiazide increases the removal of sodium and water through urine.
Excessive fluid loss may reduce blood volume and further affect kidney function.
Some patients may develop increased blood creatinine levels, which can indicate changes in kidney filtration.
In severe cases, acute kidney injury may occur.
Your healthcare provider may recommend blood tests before starting treatment and periodically afterward.
These tests help assess kidney function and determine whether the medication remains appropriate.
Micardis HCT is generally not recommended in patients with severe kidney impairment.
Contact your healthcare provider if you experience significantly reduced urination, unusual swelling, severe weakness, or persistent dizziness.
Tell your healthcare provider if you have liver disease or a history of abnormal liver function.
The liver helps process many medications and supports several important functions, including digestion and metabolism.
Telmisartan is mainly eliminated from the body through bile, a digestive fluid produced by the liver.
Bile travels through ducts into the digestive system, where it helps break down fats.
Certain liver conditions can interfere with normal bile flow.
When bile flow is reduced or blocked, telmisartan may remain in the body longer than expected.
This can increase exposure to the medication and the risk of adverse effects.
Patients with mild or moderate liver impairment may require a lower starting dose and closer monitoring.
Micardis HCT may not be appropriate for patients with severe liver impairment or certain conditions that obstruct bile flow.
Hydrochlorothiazide may also cause electrolyte changes that are particularly dangerous in people with severe liver disease.
For example, significant electrolyte imbalances can contribute to worsening confusion or other complications in susceptible patients.
Your healthcare provider will assess your liver function and determine whether Micardis HCT is suitable.
Do not take Micardis HCT if you have serious liver problems without a healthcare provider specifically assessing its safety.
Micardis HCT may increase the risk of dehydration and low blood pressure, especially in patients who already have reduced fluid levels.
Dehydration occurs when the body loses more fluid than it takes in.
Low blood volume, also called hypovolemia, means that there is not enough fluid circulating through the bloodstream.
Hydrochlorothiazide increases urine production, which helps remove excess sodium and water from the body.
However, excessive fluid loss can reduce blood volume too much.
When blood volume becomes too low, blood pressure may fall suddenly.
This may cause dizziness, weakness, lightheadedness, or fainting.
The risk is greater in people who have been vomiting, experiencing diarrhea, sweating heavily, or following a very low-sodium diet.
Older adults and people taking other diuretics may also be more vulnerable.
Your healthcare provider may need to correct dehydration or salt depletion before starting Micardis HCT.
Drink enough fluids throughout the day unless your healthcare provider has recommended restricting fluid intake.
Contact your healthcare provider if you develop persistent vomiting, severe diarrhea, excessive thirst, or symptoms of dehydration while taking Micardis HCT.
Micardis HCT may sometimes cause blood pressure to fall below the normal range.
This condition is called hypotension.
Blood pressure needs to remain high enough to deliver oxygen-rich blood to the brain, heart, kidneys, and other organs.
If blood pressure drops too low, these organs may not receive adequate blood flow.
Symptoms of hypotension may include dizziness, lightheadedness, weakness, blurred vision, or fainting.
Some patients experience these symptoms when standing up suddenly.
This is called orthostatic hypotension.
It occurs when blood pressure falls after moving from a sitting or lying position to standing.
The risk may be greater when treatment begins, the dosage increases, or the body becomes dehydrated.
To reduce the risk, stand up slowly after sitting or lying down.
If you feel dizzy, sit or lie down until the sensation passes.
Avoid driving or performing activities that require full alertness while you are experiencing these symptoms.
Contact your healthcare provider if you develop frequent dizziness, unusually low blood pressure readings, or fainting episodes.
Seek emergency medical attention if you lose consciousness or develop severe symptoms.
Micardis HCT may increase potassium levels in the blood because it contains telmisartan.
Potassium is an essential mineral that helps regulate nerve signals, muscle contractions, and heart rhythm.
The kidneys normally help maintain potassium levels within a healthy range.
Telmisartan blocks the effects of angiotensin II and can reduce the release of aldosterone, a hormone involved in potassium regulation.
As a result, the kidneys may remove less potassium from the body.
This can cause potassium to build up in the bloodstream.
The condition is called hyperkalemia.
High potassium levels may not cause noticeable symptoms at first.
However, more severe cases may cause muscle weakness, tingling, nausea, or an irregular heartbeat.
The risk may be higher in patients with kidney disease, diabetes, or those taking potassium supplements.
Hydrochlorothiazide can lower potassium levels, but this does not eliminate the risk of hyperkalemia.
Avoid potassium supplements and potassium-containing salt substitutes unless your healthcare provider specifically recommends them.
Your healthcare provider may recommend regular blood tests to monitor potassium levels during Micardis HCT treatment.
Micardis HCT may affect the balance of important minerals in your blood.
These minerals are called electrolytes.
Electrolytes include sodium, potassium, magnesium, and calcium.
They help regulate fluid balance, nerve activity, muscle movement, and normal heart function.
Hydrochlorothiazide increases the removal of sodium and water through urine.
In some patients, this can cause sodium levels to become too low.
This condition is called hyponatremia.
Symptoms may include headache, nausea, muscle cramps, weakness, and confusion.
Severe hyponatremia may cause seizures or changes in consciousness.
Hydrochlorothiazide may also lower potassium and magnesium levels while increasing calcium levels.
These changes can affect normal muscle and heart function.
Your healthcare provider may recommend blood tests to monitor electrolyte levels, particularly after starting treatment or increasing your dosage.
Seek medical attention if you develop severe muscle weakness, confusion, an irregular heartbeat, or other symptoms of a serious electrolyte imbalance.Â
Tell your healthcare provider about all medications and supplements you currently use before starting Micardis HCT.
This includes prescription medications, over-the-counter products, vitamins, and herbal supplements.
Some medications may increase the blood pressure-lowering effects of Micardis HCT.
Others may affect kidney function, potassium levels, or the medication’s effectiveness.
For example, nonsteroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen and naproxen, may reduce the effectiveness of certain blood pressure medications.
These medications may also increase the risk of kidney problems when combined with Micardis HCT, particularly in older adults or people who are dehydrated.
Potassium supplements and potassium-sparing diuretics may increase the risk of high potassium levels.
Micardis HCT should not be combined with aliskiren in patients with diabetes because this combination increases the risk of kidney problems, low blood pressure, and high potassium.
Lithium, a medication used for certain psychiatric conditions, may also build up in the bloodstream when taken with diuretics or angiotensin receptor blockers.
Some cholesterol-lowering medications, including cholestyramine and colestipol, may reduce hydrochlorothiazide absorption.
Your healthcare provider may recommend separating these medications by several hours.
Do not start, stop, or change another medication while taking Micardis HCT without consulting your healthcare provider.
Micardis HCT may cause dizziness, lightheadedness, or tiredness in some patients.
These symptoms are more likely when treatment begins or the dosage is increased.
Because Micardis HCT lowers blood pressure, some patients may experience a temporary reduction in blood flow to the brain when standing up quickly.
This may cause dizziness or a feeling that you are about to faint.
Dehydration may make these symptoms worse.
If you feel dizzy after taking Micardis HCT, sit or lie down until you feel better.
Stand up slowly and avoid sudden changes in position.
Do not drive or operate heavy machinery if you feel dizzy, unusually tired, or less alert than normal.
Your healthcare provider may recommend checking your blood pressure if these symptoms occur frequently.
Avoid driving or performing potentially dangerous activities until you know how Micardis HCT affects you.
Micardis HCT contains hydrochlorothiazide, which has been associated with an increased risk of certain types of non-melanoma skin cancer.
These include basal cell carcinoma and squamous cell carcinoma.
Basal cell carcinoma is a type of skin cancer that commonly develops on areas exposed to sunlight.
Squamous cell carcinoma may also develop on sun-exposed skin and can sometimes spread if left untreated.
Research suggests that the risk may increase with prolonged hydrochlorothiazide use and higher total exposure over time.
Hydrochlorothiazide can make the skin more sensitive to ultraviolet radiation from sunlight.
This is known as photosensitivity.
Increased sensitivity to sunlight may contribute to skin damage.
However, the available research has limitations, and not everyone taking hydrochlorothiazide will develop skin cancer.
To reduce your risk, protect your skin when spending time outdoors.
Use a broad-spectrum sunscreen with SPF 30 or higher.
Wear protective clothing, sunglasses, and a wide-brimmed hat.
Avoid tanning beds and excessive exposure to direct sunlight.
Check your skin regularly for new growths, unusual spots, or changes in existing moles.
Pay attention to sores that do not heal, skin patches that bleed repeatedly, or growths that change in size or appearance.
Contact your healthcare provider if you notice suspicious skin changes while taking Micardis HCT.
Do not stop taking the medication without discussing your treatment options with your healthcare provider.
The increased skin cancer risk is associated with hydrochlorothiazide, not specifically with telmisartan.Â
Hydrochlorothiazide may rarely cause serious eye problems.
These include acute myopia and secondary angle-closure glaucoma.
Acute myopia causes sudden changes in vision, making distant objects appear blurry.
Angle-closure glaucoma occurs when fluid cannot drain properly from the eye, causing pressure inside the eye to rise.
A sudden increase in eye pressure can damage the optic nerve.
The optic nerve carries visual information from the eye to the brain.
Symptoms may include sudden blurred vision, eye pain, headache, or redness.
These problems may develop within hours or weeks after starting hydrochlorothiazide.
Without prompt treatment, severe increases in eye pressure may lead to permanent vision loss.
Seek urgent medical attention if you develop sudden blurred vision, eye pain, or other significant changes in eyesight while taking Micardis HCT.
Tell your healthcare provider if you have diabetes before starting Micardis HCT.
Hydrochlorothiazide may affect how the body regulates blood sugar.
In some patients, this medication can increase blood glucose levels or make diabetes more difficult to control.
The effect may be more noticeable in people who already have diabetes or reduced glucose tolerance.
Your healthcare provider may recommend monitoring your blood sugar more frequently after starting treatment.
If you take insulin or another diabetes medication, your treatment may need adjustment.
However, do not change your diabetes medication dosage without medical advice.
Maintaining healthy blood sugar levels remains important while treating high blood pressure.
Continue following your recommended blood sugar monitoring plan and tell your healthcare provider if your glucose readings become consistently higher than usual.
Tell your healthcare provider if you have gout or a history of elevated uric acid levels.
Gout is a type of inflammatory arthritis caused by the buildup of uric acid crystals in the joints.
These crystals can trigger sudden episodes of severe joint pain, swelling, redness, and tenderness.
Gout commonly affects the big toe but can also involve the ankles, knees, and other joints.
Hydrochlorothiazide may increase uric acid levels because it reduces the amount of uric acid removed through urine.
This can increase the risk of gout attacks in susceptible patients.
If you already have gout, your healthcare provider may recommend additional monitoring or another blood pressure treatment.
Contact your healthcare provider if you develop sudden severe joint pain, swelling, or redness while taking Micardis HCT.
Older adults may be more sensitive to certain effects of Micardis HCT.
Kidney function often changes with age, which can affect how the body responds to blood pressure medications.
Older adults may also be more likely to experience dehydration, electrolyte imbalances, or dizziness.
These effects can increase the risk of falls and other complications.
Your healthcare provider may assess your kidney function, blood pressure, and electrolyte levels before starting treatment.
A lower starting dose or closer monitoring may be appropriate for some patients.
If you feel dizzy when standing up, move slowly and use support when necessary.
Tell your healthcare provider if you experience frequent dizziness, weakness, falls, or unusual changes in urination.
Take Micardis HCT exactly as prescribed by your healthcare provider.
The medication is usually taken once daily, with or without food.
Taking Micardis HCT regularly helps maintain blood pressure control throughout the day.
Some patients may notice improvements in their blood pressure readings during the first few days of treatment.
However, the full blood pressure-lowering benefits may take several weeks to develop.
High blood pressure often causes no noticeable symptoms.
For this reason, you may feel healthy even when your blood pressure remains elevated.
Do not stop taking Micardis HCT simply because you feel well or your blood pressure readings have improved.
Stopping treatment without medical advice may cause your blood pressure to rise again.
Over time, uncontrolled hypertension can increase the risk of heart attack, stroke, heart failure, and kidney damage.
Your healthcare provider may adjust your dosage based on your blood pressure readings and laboratory results.
Continue taking Micardis HCT according to your prescribed schedule unless your healthcare provider recommends a change or a serious reaction requires immediate medical attention.
Contact your healthcare provider if you experience persistent dizziness, unusual weakness, muscle cramps, excessive thirst, or changes in urination.
You should also seek medical advice if your blood pressure remains consistently higher or lower than your recommended target range.
Persistent vomiting, diarrhea, or dehydration may require temporary adjustments to your treatment.
Your healthcare provider may recommend blood tests to evaluate kidney function and electrolyte levels.
Report any unusual skin changes, new rashes, or signs of medication intolerance.
Seek emergency medical attention if you experience difficulty breathing, swelling of the face or throat, fainting with serious symptoms, chest pain, sudden vision changes, or signs of a severe allergic reaction.
If you become pregnant during treatment, stop taking Micardis HCT and contact your healthcare provider immediately.
Continue monitoring your blood pressure regularly and attend recommended follow-up appointments to help ensure that your treatment remains safe and effective.
No. Do not stop taking Micardis HCT without consulting your healthcare provider. Micardis HCT helps control high blood pressure, but it does not cure hypertension. Your blood pressure may improve because the medication is working. Stopping treatment suddenly may cause your blood pressure to rise again, increasing the risk of heart attack, stroke, and kidney problems. Continue taking Micardis HCT exactly as prescribed, even if you feel well or your blood pressure readings return to normal. Your healthcare provider will determine whether your dosage needs to be adjusted.
Micardis HCT may be taken with certain other medications when recommended by your healthcare provider. However, some medications can interact with Micardis HCT and increase the risk of side effects. For example, potassium supplements may increase potassium levels, while pain relievers such as ibuprofen and naproxen may affect kidney function or reduce the medication’s blood pressure-lowering effects. Other blood pressure medications may also cause your blood pressure to drop too low. Tell your healthcare provider about all prescription medications, over-the-counter products, vitamins, and herbal supplements you currently use. Do not start, stop, or change another medication without medical advice.
Micardis HCT begins lowering blood pressure within a few hours after taking a dose. However, it may take several weeks to experience its full benefits. Some patients notice improvements in their blood pressure readings during the first few days of treatment, while the full blood pressure-lowering effect may take approximately four weeks. Your healthcare provider may monitor your blood pressure and adjust your dosage based on your response. Continue taking Micardis HCT at approximately the same time each day, even if you do not notice immediate changes in how you feel. Regular blood pressure monitoring helps determine how well the medication is working.
No. Micardis HCT must not be used during pregnancy because it can cause serious harm to an unborn baby. Telmisartan can interfere with fetal kidney development and function, particularly during the second and third trimesters. This may lead to low amniotic fluid levels, kidney damage, and other serious complications. If you are pregnant, planning to become pregnant, or think you may be pregnant, inform your healthcare provider immediately. If pregnancy occurs while taking Micardis HCT, stop taking the medication and contact your healthcare provider right away. Your healthcare provider can recommend a safer treatment to help control your blood pressure during pregnancy.
| Generic name: | Telmisartan/Hctz |
|---|---|
| Formulation: | Tablet |
| Strength(s): | 40/12.5mg, 80/12.5mg, 80/25mg |
| Quantities Available: | 28, 84, 90, 100 |
Our online Canadian Pharmacy is known for high standards of quality, safety, and efficiency when it comes to medications.
Our pharmacy offers lower prices on prescription drugs compared to traditional pharmacies.
When ordering Micardis HCT (telmisartan/hctz) from a Canadian pharmacy, you can typically purchase up to a 90-day supply at one time, which is common for prescription medications to ensure adequate management of chronic conditions without frequent refills.
Here’s what you need to know:
Dosage and Quantity: Micardis HCT is commonly prescribed in dosages of 40 mg/12.5 mg, 80 mg/25 mg, or 80 mg/12.5 mg, taken once daily. For a 90-day supply, this means you would order 90 tablets (90 days x 1 tablet per day).
Yes, we sell telmisartan/hctz on our website. You can enjoy low prices when you order through us. To purchase telmisartan/hctz, you will need a valid prescription from your healthcare provider. We require this prescription to dispense the medication safely and appropriately. You can submit your prescription by mailing it to us, faxing it, or uploading it through your online account.
Yes, we ship Micardis HCT (telmisartan/hctz) to both the United States and Puerto Rico.
Watch how Online Pharmacies Canada is helping customers save money on their medications.
Online Pharmacies Canada has provided information from third parties intended to increase awareness and does not contain all the information about Micardis HCT (Telmisartan/Hctz). Talk to your doctor or other qualified medical practitioners for medical attention or advice, or if you have any concerns about Micardis HCT (Telmisartan/Hctz).
REVIEWS